Larvol Delta - Atossa-Doses-First-Patient-in-Phase-2-Neoadjuvant-Clinical-Study-of-ZEndoxifen-in-Premenopausal-Women-with-ERHER2-Breast-Cancer

Z-endoxifen - Atossa Therap

https://www.globenewswire.com/news-release/2023/02/23/2614454/0/en/Atossa-Doses-First-Patient-in-Phase-2-Neoadjuvant-Clinical-Study-of-Z-Endoxifen-in-Premenopausal-Women-with-ER-HER2-Breast-Cancer.html

Feb 23, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next